top of page

Free Biopharma Daily Stock Updates - 03/17/22

  • Writer: BPIQ
    BPIQ
  • Mar 17, 2022
  • 1 min read

$XBI $89.56| +3.91%

Covid Updates

$MRNA -0.5% Health Canada Authorizes Moderna's COVID-19 Vaccine in Children (6-11 Years) source


$EIGR +40.3% Eiger's Single-dose Peginterferon Lambda for COVID-19 Reduced Risk of Hospitalization or ER Visits by 50% in a Predominantly Vaccinated Population in Phase 3 TOGETHER Study source



Pipeline Updates

$HRTX +7.0% Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain source


$AQST +10.3% Aquestive Therapeutics Receives FDA Fast Track Designation For AQST-109 For Emergency Treatment Of Allergic Reactions Including Anaphylaxis source


$IFRX +12.8% InflaRx Receives Corrected Advice Letter from FDA Related to Phase III Program for Vilobelimab in Hidradenitis Suppurativa source


Business Updates

$


Posted by JM

 
 
 

Comments

bottom of page